A multicentre, open-label, non-inferiority sequential study, evaluating the efficacy, safety, tolerability and acceptability of ADV7103 compared to standard of care in distal renal tubular acidosis patients.

Trial Profile

A multicentre, open-label, non-inferiority sequential study, evaluating the efficacy, safety, tolerability and acceptability of ADV7103 compared to standard of care in distal renal tubular acidosis patients.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Potassium bicarbonate/potassium citrate (Primary) ; Potassium bicarbonate; Potassium citrate; Sodium bicarbonate; Sodium citrate
  • Indications Metabolic acidosis; Renal tubular acidosis
  • Focus Registrational; Therapeutic Use
  • Sponsors Advicenne
  • Most Recent Events

    • 20 Apr 2017 Status changed from recruiting to completed.
    • 20 Mar 2017 According to an Advicenne media release, the company expects to announce the results of this trial during summer 2017.
    • 09 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top